ApoM-Bound S1P Identified as Regulator of Endothelial Activity in Choroidal Neovascularization

Recent research has identified a potential mechanism by which ApoM-bound sphingosine-1-phosphate (S1P) may impact choroidal neovascularization (CNV), a condition associated with abnormal blood vessel growth in the eye. The study highlights the role of S1P, specifically when bound to apolipoprotein M (ApoM), in regulating endothelial cell activity and reducing vascular leakage. Findings indicate that this interaction occurs through the activation of S1P receptor 1 (S1PR1), suggesting its involvement in mitigating CNV progression.

The research focuses on how ApoM-S1P influences endothelial cells, which are critical for maintaining vascular integrity. By engaging S1PR1, ApoM-S1P appears to reduce pathological blood vessel formation and leakage within the choroid layer of the eye. These results provide insight into the molecular pathways underlying CNV and suggest potential therapeutic targets for conditions involving abnormal ocular vascularization. Further studies are expected to explore these findings and their implications for treating diseases such as age-related macular degeneration.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: January 24, 2026

Author

GOAI